• Home
  • E-submission
  • Sitemap
  • Contact us
  • Search
  • Advanced Search
Intest Res Search

CLOSE

‘Intestinal Research’ (Intest Res) is the joint official publication of the Asian Organization for Crohn's and Colitis (AOCC), Chinese Society of IBD (CSIBD), Japanese Society for IBD (JSIBD), Korean Association for the Study of Intestinal Diseases (KASID), Taiwan Society of IBD (TSIBD) and Colitis Crohn's Foundation (India) (CCF, india).
The aim of the Journal is to provide broad and in-depth analysis of intestinal diseases, especially inflammatory bowel disease, which shows increasing tendency and significance.As a Journal specialized in clinical and translational research in gastroenterology, it encompasses multiple aspects of diseases originated from the small and large intestines.

Review

April 28, 2023


First aid with color atlas for the use of intestinal ultrasound for inflammatory bowel disease in daily clinical practice
Jun Miyoshi, Hiromu Morikubo, Hiromi Yonezawa, et al.
Intest Res. 2023;21(2):177-188.

Intestinal ultrasound (IUS) is a promising modality for the management of inflammatory bowel disease (IBD) and has the potential to particularly contribute in monitoring disease activity, an advantage crucial for...

Review

May 31, 2022


An Asian perspective on irritable bowel syndrome
Kee Wook Jung, Seung-Jae Myung
Intest Res. 2023;21(2):189-195.
Irritable bowel syndrome (IBS) is a prevalent chronic disorder, and its epidemiology depends on the diagnostic criteria used. Recently, the Rome IV criteria for IBS were published by changing the...

Statement

August 8, 2022


Proposal of novel staging system CNM (Crohn’s primary site, nodes, mesentery) to predict postoperative recurrence of Crohn’s disease
Guduru Venkat Rao, Partha Pal, Anuradha Sekaran, et al.
Intest Res. 2023;21(2):196-204.

After oncologic resection, histological grading and staging of the tumor give important prognostic information about the future risk of recurrence and hence influence the subsequent management plan. Several studies and...

Original Article

December 15, 2022


Performing colonoscopy before steroid induction is associated with shorter steroid use in patients with ulcerative colitis
Taku Kobayashi, Eri Udagawa, Lisa Hirose, et al.
Intest Res. 2023;21(2):205-215.

Background/Aims: Risks of long-term steroid use in patients with ulcerative colitis (UC) outweigh the benefits, thus dosing should be tapered once a response is achieved. Colonoscopy is a key technique...

Original Article

August 8, 2022


Clinical spectrum of elderly-onset inflammatory bowel disease in India
Yogesh Kumar Gupta, Arshdeep Singh, Vikram Narang, et al.
Intest Res. 2023;21(2):216-225.

Background/Aims: Inflammatory bowel disease (IBD) is increasingly being recognized in elderly patients. Data on clinical spectrum of elderly-onset IBD patients is lacking from India. Methods: A cross-sectional retrospective analysis of a...

Original Article

June 13, 2022


Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas
Karan Sachdeva, Peeyush Kumar, Bhaskar Kante, et al.
Intest Res. 2023;21(2):226-234.

Background/Aims: Intestinal tuberculosis (ITB) and Crohn’s disease (CD) frequently present with a diagnostic dilemma because of similar presentation. Interferon-gamma release assay (IGRA) has been used in differentiating ITB from CD,...

Original Article

December 2, 2022


Laparoscopic surgery contributes to a decrease in short-term complications in surgical ulcerative colitis patients during 2008–2017: a multicenter retrospective study in China
Zerong Cai, Xiaosheng He, Jianfeng Gong, et al.
Intest Res. 2023;21(2):235-243.

Background/Aims: The aim of this study was to analyze the chronological changes in postoperative complications in surgical ulcerative colitis patients over the past decade in China and to investigate the...

Original Article

August 8, 2022


Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease
Yu Kyung Jun, Hyuk Yoon, Seong-Joon Koh, et al.
Intest Res. 2023;21(2):244-251.

Background/Aims: Patients with inflammatory bowel disease (IBD) are diagnosed with ankylosing spondylitis (AS) often. However, the disease course of patients with both IBD and AS is not well understood. This...

Original Article

December 2, 2022


Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study
Eun Hye Oh, Ye-Jee Kim, Minju Kim, et al.
Intest Res. 2023;21(2):252-265.

Background/Aims: We conducted a nationwide population-based study to investigate incidence rates of colorectal and biliary cancers according to accompanying primary sclerosing cholangitis in Korean ulcerative colitis patients. Methods: We used...
Current Issue
Volume 21(2); Apr 2023
Concomitant ankylosing spondylitis with inflammatory bowel disease: Clinical significance in terms of clinical outcomes

Epub May 9, 2023
Are the incidence rates of hospitalized infections, herpes zoster, and malignancies different depending on treatment drugs in patients with ulcerative colitis?

Epub February 3, 2023
Can educational training decrease excessive and inappropriate steroid use in patients with inflammatory bowel disease?

Epub November 3, 2022
Is bile acid metabolism related to dysbiosis in patients with Crohn’s disease?

Epub August 1, 2022
Is fecal microbiota transplantation effective in corticosteroid-dependent ulcerative colitis?

Epub April 29, 2022
Are thiopurines safe and effective for patients with NUDT15 heterozygosity?

Epub February 7, 2022
How often is immunoglobulin A nephropathy associated in patients with inflammatory bowel diseases?

Epub November 2, 2021
Could the geographic area influence the demographic profile of IBD patients in India?

Epub April 29, 2021
Could melatonin ameliorate the intestinal inflammation by modulating intestinal microbial composition?

Epub August 10, 2020
What are the risk factors for impaired ovarian reserve in young women of reproductive age with Crohn's disease?

Epub April 22, 2020
Who should continue the budesonide 2-mg foam treatment for up to week 6 in patients with mild-to-moderate distal ulcerative colitis?

Epub February 18, 2020
How common is family history of inflammatory bowel disease and how does it relate to the prognosis in patients with inflammatory bowel disease in Asia?

Epub October 13, 2019
Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study

Epub August 2, 2019
Influence of anti-tumor necrosis factor-alpha therapy on pregnant women with inflammatory bowel disease and their children’s immunity

Epub April 23, 2019
Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis

Epub February 7, 2019
Fecal immunochemical test and fecal calprotectin in ulcerative colitis

Epub November 1, 2018
Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease

Epub August 9, 2018
Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study

Epub May 8, 2018
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment

Epub February 5, 2018
Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease

Epub November 2, 2017
Long-term safety and efficacy of adalimumab for intestinal Behçet's disease

Epub September 1, 2017
  • SCImago Journal & Country Rank
  • AOCC 2018
  • CSIBD
  • JSIBD
  • kasid
  • TSIBD
  • CCF
  • PubMed Central
  • PubMed
  • KoreaMed
  • KoMCI
  • Scopus
  • Directory of Open Access Journals (DOAJ)
  • GoogleScholar
  • EBSCO
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID
  • COPE
  • KOFST
  • TrendMD
ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145    Fax: +82-2-957-6146    E-mail: thekasid@irjournal.org                

Copyright © 2023 by Korean Association for the Study of Intestinal Diseases.

Developed in M2PI

Close layer
prev next
Close layer
prev next